Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 5/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30574265 | 0.90 | C5AR1 (0.56) | F2OPRM1OPRD1 | |
| SCHEMBL29390515 | 0.90 | OPRM1 (0.52) | F2OPRM1OPRD1OPRK1 | |
| SCHEMBL29794087 | 0.87 | F2 (0.58) | F2OPRM1OPRD1 | |
| SCHEMBL29655724 | 0.86 | F2 (0.60) | F2 | |
| SCHEMBL30350823 | 0.86 | APLNR (0.47) | F2 | |
| SCHEMBL29590405 | 0.85 | F2 (0.46) | F2OPRM1OPRD1OPRK1 | |
| SCHEMBL30272533 | 0.85 | F2 (0.56) | F2 | |
| SCHEMBL29630549 | 0.85 | F2 (0.45) | F2OPRM1OPRD1OPRK1 | |
| SCHEMBL29531965 | 0.83 | SLC6A2 (0.50) | F2OPRM1OPRD1OPRK1 | |
| SCHEMBL29568748 | 0.83 | APLNR (0.41) | F2OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4334341-A2 | METHODS FOR STIMULATING AND TRANSDUCING T CELLS | Juno Therapeutics GmbH (DE) | 2024-03-13 | — | — | EP | disclosed |
| EP-4240756-A1 | CELLS EXPRESSING A CHIMERIC RECEPTOR FROM A MODIFIED INVARIANT CD3 IMMUNOGLOBULIN SUPERFAMILY CHAIN LOCUS AND RELATED POLYNUCLEOTIDES AND METHODS | Juno Therapeutics, Inc. (US) | 2023-09-13 | — | — | EP | disclosed |
| EP-4150057-A2 | PROCESS FOR PRODUCING DONOR-BATCHED CELLS EXPRESSING A RECOMBINANT RECEPTOR | Juno Therapeutics, Inc. (US) | 2023-03-22 | — | — | EP | disclosed |
| WO-2022234009-A2 | METHODS FOR STIMULATING AND TRANSDUCING T CELLS | JUNO THERAPEUTICS GMBH (DE) | 2022-11-10 | — | — | WO | disclosed |
| WO-2022098787-A1 | CELLS EXPRESSING A CHIMERIC RECEPTOR FROM A MODIFIED INVARIANT CD3 IMMUNOGLOBULIN SUPERFAMILY CHAIN LOCUS AND RELATED POLYNUCLEOTIDES AND METHODS | JUNO THERAPEUTICS, INC. (US) | 2022-05-12 | — | — | WO | disclosed |